MX2023005451A - Capsulas de gel blando de liberacion retardada. - Google Patents
Capsulas de gel blando de liberacion retardada.Info
- Publication number
- MX2023005451A MX2023005451A MX2023005451A MX2023005451A MX2023005451A MX 2023005451 A MX2023005451 A MX 2023005451A MX 2023005451 A MX2023005451 A MX 2023005451A MX 2023005451 A MX2023005451 A MX 2023005451A MX 2023005451 A MX2023005451 A MX 2023005451A
- Authority
- MX
- Mexico
- Prior art keywords
- delayed release
- softgel capsules
- shell composition
- pectin
- dextrose
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title abstract 3
- 230000003111 delayed effect Effects 0.000 title abstract 3
- 230000001419 dependent effect Effects 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 108010010803 Gelatin Proteins 0.000 abstract 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 2
- 239000008121 dextrose Substances 0.000 abstract 2
- 229920000159 gelatin Polymers 0.000 abstract 2
- 239000008273 gelatin Substances 0.000 abstract 2
- 235000019322 gelatine Nutrition 0.000 abstract 2
- 235000011852 gelatine desserts Nutrition 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 235000010987 pectin Nutrition 0.000 abstract 2
- 229920001277 pectin Polymers 0.000 abstract 2
- 239000001814 pectin Substances 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 230000002028 premature Effects 0.000 abstract 1
- 229920001059 synthetic polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Marine Sciences & Fisheries (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Las cápsulas de gel blando de liberación retardada incluyen un material de relleno y una composición de la cubierta dependiente del pH. En una modalidad, la composición de la cubierta dependiente del pH incluye gelatina, pectina, dextrosa y de aproximadamente 0.5 % a aproximadamente 10 % en peso de un polímero sintético. En una modalidad alternativa, la composición de la cubierta dependiente del pH incluye gelatina, pectina, dextrosa y un ácido orgánico. La naturaleza de liberación retardada de las cápsulas inhibe la liberación prematura del material de relleno en pH ácidos (tal como un pH de cualquiera de aproximadamente 1.2 a aproximadamente 6).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063112453P | 2020-11-11 | 2020-11-11 | |
| PCT/US2021/072326 WO2022104339A1 (en) | 2020-11-11 | 2021-11-10 | Delayed release softgel capsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023005451A true MX2023005451A (es) | 2023-05-23 |
Family
ID=81601948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023005451A MX2023005451A (es) | 2020-11-11 | 2021-11-10 | Capsulas de gel blando de liberacion retardada. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230404926A1 (es) |
| EP (1) | EP4243772A4 (es) |
| JP (1) | JP2023548711A (es) |
| KR (1) | KR20230106642A (es) |
| CN (1) | CN116648238A (es) |
| AR (1) | AR124043A1 (es) |
| AU (1) | AU2021379780A1 (es) |
| CA (1) | CA3197522A1 (es) |
| CO (1) | CO2023007162A2 (es) |
| IL (1) | IL302753A (es) |
| MX (1) | MX2023005451A (es) |
| TW (1) | TW202233164A (es) |
| WO (1) | WO2022104339A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1030925B1 (nl) * | 2022-09-29 | 2024-04-29 | Oystershell Nv | Zachte gummy |
| BE1030928B1 (nl) * | 2022-09-29 | 2024-04-29 | Oystershell Nv | Zachte gummy |
| DE202023105687U1 (de) * | 2022-09-29 | 2024-01-29 | Oystershell Nv | Weichgummi |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013200828A1 (en) * | 2002-12-18 | 2013-03-07 | Pain Therapeutics | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| GB201304662D0 (en) * | 2013-03-14 | 2013-05-01 | Sigmoid Pharma Ltd | Compositions |
| WO2015200149A1 (en) * | 2014-06-23 | 2015-12-30 | Banner Life Sciences Llc | All natural enteric soft capsules comprising active ingredients |
| US20180049988A1 (en) * | 2016-08-17 | 2018-02-22 | Eupraxia Pharmaceuticals Inc. | Sustained local delivery of drugs including antibiotics |
| BR112021024375A2 (pt) * | 2019-06-03 | 2022-04-19 | Scherer Technologies Llc R P | Cápsulas de softgel de liberação retardada |
| JP2022554247A (ja) * | 2019-10-28 | 2022-12-28 | アール．ピー．シェーラー テクノロジーズ，エルエルシー | より高いｐｈ環境における遅延放出ソフトゲルカプセル |
-
2021
- 2021-11-10 US US18/036,209 patent/US20230404926A1/en active Pending
- 2021-11-10 EP EP21893068.3A patent/EP4243772A4/en active Pending
- 2021-11-10 KR KR1020237018747A patent/KR20230106642A/ko unknown
- 2021-11-10 CA CA3197522A patent/CA3197522A1/en active Pending
- 2021-11-10 IL IL302753A patent/IL302753A/en unknown
- 2021-11-10 WO PCT/US2021/072326 patent/WO2022104339A1/en active Application Filing
- 2021-11-10 AU AU2021379780A patent/AU2021379780A1/en active Pending
- 2021-11-10 CN CN202180089202.6A patent/CN116648238A/zh active Pending
- 2021-11-10 JP JP2023527995A patent/JP2023548711A/ja active Pending
- 2021-11-10 MX MX2023005451A patent/MX2023005451A/es unknown
- 2021-11-11 AR ARP210103125A patent/AR124043A1/es unknown
- 2021-11-11 TW TW110142057A patent/TW202233164A/zh unknown
-
2023
- 2023-05-30 CO CONC2023/0007162A patent/CO2023007162A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20230404926A1 (en) | 2023-12-21 |
| AR124043A1 (es) | 2023-02-08 |
| WO2022104339A1 (en) | 2022-05-19 |
| JP2023548711A (ja) | 2023-11-20 |
| TW202233164A (zh) | 2022-09-01 |
| KR20230106642A (ko) | 2023-07-13 |
| EP4243772A4 (en) | 2024-10-23 |
| AU2021379780A1 (en) | 2023-07-06 |
| EP4243772A1 (en) | 2023-09-20 |
| CN116648238A (zh) | 2023-08-25 |
| IL302753A (en) | 2023-07-01 |
| CO2023007162A2 (es) | 2023-06-20 |
| CA3197522A1 (en) | 2022-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023005451A (es) | Capsulas de gel blando de liberacion retardada. | |
| MX2023005450A (es) | Capsulas de gel blando de liberacion retardada. | |
| BR112021020485A2 (pt) | Produto destinado ao consumidor com liberação controlada, composições de microcápsula de núcleo-invólucro biodegradável | |
| EP2172225A8 (en) | Seamless capsule | |
| EA201170610A1 (ru) | Композиции антиперспиранта | |
| MX2021014922A (es) | Capsulas de gel blando de liberacion retardada. | |
| WO2003103582A3 (en) | REDUCED CROSSLINKING OF GELATIN | |
| MX2022005050A (es) | Cápsulas de gelatina blanda de liberación retardada en entorno de ph más alto. | |
| NZ596403A (en) | Microcapsules with improved shells with wax in the outer shell | |
| CY1121942T1 (el) | Συνθεσεις που σχηματιζουν κελυφος για μαλακες καψουλες και μαλακες καψουλες | |
| MX2022013695A (es) | Composicion encapsulada de microcapsulas de nucleo-cubierta y proceso para su preparacion. | |
| MX2019009936A (es) | Composicion solida reforzadora del aroma. | |
| ECSP17079888A (es) | Cartucho biodegradable para escopetas | |
| MY184987A (en) | Microcapsules comprising lutein or lutein ester | |
| MX2023012880A (es) | Capsulas de gel blando entericas. | |
| ZA202005153B (en) | Enteric softgel capsules | |
| CO6630089A2 (es) | Composicion de encapsulamiento de liberacion rapida | |
| BR112021026913A2 (pt) | Artigo absorvente | |
| MX2022015160A (es) | Capsulas de gelatina blanda de liberacion retardada. | |
| MX2024000409A (es) | Capsula de gelatina blanda. | |
| MX2015002976A (es) | Composicion farmaceutica. | |
| BR112021006627A2 (pt) | composição líquida encapsulada | |
| MX2023004418A (es) | Capsulas de gel blando de liberacion modificada. | |
| MX2020005796A (es) | Composiciones que comprenden microcapsulas sensibles al ph. | |
| MX2019010229A (es) | Composicion para la liberacion controlada de sustancias fisiologicamente activas y proceso para su preparacion. |